Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JG.3.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
JG.3.3NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
JG.3.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JG.3.3NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
JG.3.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JG.3.3NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
JG.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JG.3.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JG.3.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
JG.3.3NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
JG.3.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JG.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.3.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JG.3.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JG.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JG.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JG.3.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JG.3.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JG.3.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
JG.3.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
JG.3.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JG.3.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JG.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KE.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
KE.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
KE.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KE.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
KE.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
KE.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
KE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KE.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KE.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
KE.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KE.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
KE.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KE.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KE.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KE.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KE.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
KE.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
KE.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
KE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KE.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22683US
HV.1.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used